Nathan Lawrentschuk

Professor Director

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Nathan Lawrentschuk serves as the Director at The Royal Melbourne Hospital Royal Park Campus in Australia. His research focuses on oncology, with recent publications addressing topics such as prostate cancer detection and management, kidney cancer treatment outcomes, and innovative assessment techniques in surgical oncology. He is actively involved in evaluating the implications of emerging diagnostic technologies, including PSMA PET/CT, and assessing the quality of medical information provided by artificial intelligence.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Weranja Ranasinghe

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jeremy Lewin

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Damien Bolton

AUSTRALIA

View details

Shomik Sengupta

Professor of Surgery

MONASH UNIVERSITY

AUSTRALIA

View details

Michael Chao

University of Melbourne

AUSTRALIA

View details

Declan Murphy

sir peter maccallum department of oncology university of melbourne melbourne victoria australia

AUSTRALIA

View details

Daniel Moon

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nathan Lawrentschuk

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia

Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma

The role of PSMA PET/CT in staging patients with intermediate‐risk prostate cancer

End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detection

New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy

Active surveillance in prostate cancer: when to exit and what are the options?

Quality of information on hypospadias from artificial intelligence chatbots: How safe is AI for patient and family information?

PSMA PET in Favourable Intermediate-Risk Prostate Cancer? Gold Mine or Money Pit

Lutetium‐177 PSMA – the new snake oil? An Australian experience

Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies

Rectal Spacer Reduces Gastrointestinal Side Effects of Radiation Post Radical Prostatectomy

Bleeding us dry: The financial impact of full blood examinations in the immediate postoperative period

Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: an operative approach to large renal angiomyolipoma associated with lymphangioleiomyomatosis

Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancer

A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer

‘Case of the Month’ from Epworth Healthcare, Epworth, Australia: Fournier's gangrene following routine surgery

Role of diverting colostomy and reconstruction in managing Fournier's gangrene—a narrative review

Beware of Bipolar Transurethral Resection of Prostate in Patients with Previously Inserted Metallic Prostate Stapling Devices

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery

The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer

Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy

How PSMA PET is refining risk calculators in the primary prostate diagnostic pathway

The Pen is Mightier than the Machine ‐ Artificial Intelligence Image Generators in Urology

Is genetic testing coming of age in advanced prostate cancer?

Government Funding of FDG‐PET Imaging In Rare Urological Cancers‐ Better Data, Better Outcomes.

Decade‐long trends in prostate cancer biopsy grade groups and treatment within a population‐based registry

Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports

New Approaches to Targeting Epigenetic Regulation in Bladder Cancer

Point-Counterpoint: Active Surveillance in the “Real World” Has Far More Risks Than We Appreciate

Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer

Collaborators (7)

Weranja Ranasinghe

Jeremy Lewin

Damien Bolton

Shomik Sengupta

Michael Chao

Declan Murphy

Daniel Moon

Make your next move.